JAK / Stat

2 Item(s)

per page

Set Descending Direction
  1. PRT 062070 (Cerdulatinib)

    Catalog No. A14147
    Quick View
    Dual Syk and JAK inhibitor
    PRT062070 is a novel, oral, dual spleen tyrosine kinase (Syk) and janus kinase (JAK) inhibitor. Cerdulatinib preferentially inhibited JAK1 and JAK3 dependent cytokine mediated signaling and functional responses in various cell types. Learn More
  2. Cerdulatinib

    Catalog No. A14210
    Quick View
    multi-targeted tyrosine kinase inhibitor
    Cerdulatinib (PRT-062070) is an oral active, multi-targeted tyrosine kinase inhibitor with IC50 of 12 nM/6 nM/8 nM/0.5 nM and 32 nM for JAK1/JAK2/JAK3/TYK2 and Syk, respectively. Learn More

2 Item(s)

per page

Set Descending Direction
Rewards